Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Zogenix Inc (NQ: ZGNX )

18.32 USD -0.32 (-1.74%)
Streaming Delayed Price Updated: 3:20 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 682,141
Open 18.98
Bid (Size) 18.30 (1)
Ask (Size) 18.33 (1)
Prev. Close 18.64
Today's Range 18.11 - 18.98
52wk Range 16.65 - 56.01
Shares Outstanding 35,223,373
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Zogenix Announces Preliminary, Unaudited Fourth Quarter 2020 Net Product Sales
From GlobeNewswire News Releases
The European Commission Approves Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Dravet Syndrome
From GlobeNewswire News Releases

Performance

YTD
-7.69%
-7.69%
1 Month
-9.38%
-9.38%
3 Month
-9.24%
-9.24%
6 Month
-36.84%
-36.84%
1 Year
-66.43%
-66.43%

More News

Read More
Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
From PR Newswire
Zogenix and Leading Experts to Present New Rare Epilepsy Data at AES 2020
From GlobeNewswire News Releases
Zogenix to Participate in the Stifel 2020 Virtual Healthcare Conference
From GlobeNewswire News Releases
Zogenix Provides Corporate Update and Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Zogenix Announces Date Change for Third Quarter 2020 Financial Results and Conference Call and Webcast to November 9
From GlobeNewswire News Releases
Zogenix to Release Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10
From GlobeNewswire News Releases
First Week of March 19th Options Trading For Zogenix (ZGNX)
Tags Stocks
From Market News Video
Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome
From GlobeNewswire News Releases
Analysts See 28% Upside For The Holdings of XPH
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.